article · Pharmacoepidemiology and Drug Safety
Warfarin therapy in Sub-Saharan Africa is associated with considerable bleeding and thromboembolic risks. The robustness of these findings was confirmed through meta-regression and sensitivity analyses, underscoring the need for improved therapeutic monitoring and safety strategies in this population.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/pds.70225
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
